4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane
C19H29ClN4S — CID 144961800
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane
4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane (PubChem CID 144961800) has the molecular formula C19H29ClN4S and a molecular weight of 380.99 g/mol. Its IUPAC name is 4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane.
Molecular Properties
| Compound Name | 4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane |
|---|---|
| PubChem CID | 144961800 |
| Molecular Formula | C19H29ClN4S |
| Molecular Weight | 380.99 g/mol |
| Exact Mass | 380.18 |
| IUPAC Name | 4-chloro-5-[(2E,4Z)-6-methylhepta-2,4,6-trien-3-yl]sulfanyl-2-(4-methylpiperazin-1-yl)pyrimidine;ethane |
| SMILES | C=C(C)/C=C\C(=C/C)Sc1cnc(N2CCN(C)CC2)nc1Cl.CC |
| InChI | InChI=1S/C17H23ClN4S.C2H6/c1-5-14(7-6-13(2)3)23-15-12-19-17(20-16(15)18)22-10-8-21(4)9-11-22;1-2/h5-7,12H,2,8-11H2,1,3-4H3;1-2H3/b7-6-,14-5-; |
| InChIKey | VGURAURDGYTXCH-SPIMYXQLSA-N |
| XLogP | 5.04 |
| TPSA | 32.26 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 380.99 |
| LogP ≤ 5 | 5.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144961800 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.